<SEC-DOCUMENT>0001104659-23-105599-index.html : 20231002 <SEC-HEADER>0001104659-23-105599.hdr.sgml : 20231002 <ACCEPTANCE-DATETIME>20231002063102 ACCESSION NUMBER: 0001104659-23-105599 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 13 FILED AS OF DATE: 20231002 DATE AS OF CHANGE: 20231002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Data Knights Acquisition Corp. CENTRAL INDEX KEY: 0001849380 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 862076743 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-266274 FILM NUMBER: 231297657 BUSINESS ADDRESS: STREET 1: TRIDENT COURT, 1 OAKCROFT ROAD STREET 2: CHESSINGTON CITY: SURREY STATE: X0 ZIP: KT9 1BD BUSINESS PHONE: 011-44-208-090-2009 MAIL ADDRESS: STREET 1: TRIDENT COURT, 1 OAKCROFT ROAD STREET 2: CHESSINGTON CITY: SURREY STATE: X0 ZIP: KT9 1BD </SEC-HEADER> <DOCUMENT> <TYPE>424B3 <SEQUENCE>1 <FILENAME>tm2220656-37_424b3.htm <DESCRIPTION>424B3 <TEXT> Document 1 - file: tm2220656-37_424b3.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>tm2220656d3-ph_network4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: tm2220656d3-ph_network4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tm2220656d3-tbl_real4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tm2220656d3-tbl_real4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tm2220656d3-bc_patient4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tm2220656d3-bc_patient4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm2220656d3-fc_study4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm2220656d3-fc_study4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tm2220656d3-lc_cycle4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tm2220656d3-lc_cycle4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>tm2220656d3-bc_market4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: tm2220656d3-bc_market4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>tm2220656d3-bc_pharma4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: tm2220656d3-bc_pharma4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>tm2220656d3-bc_cagr4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: tm2220656d3-bc_cagr4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>tm2220656d3-lc_levera4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 10 - file: tm2220656d3-lc_levera4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>tm2220656d9-tbl_irwdbw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 11 - file: tm2220656d9-tbl_irwdbw.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>12 <FILENAME>lg_marshallstevens-4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 12 - file: lg_marshallstevens-4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>13 <FILENAME>sg_marshallstevens-bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 13 - file: sg_marshallstevens-bw.jpg
</DOCUMENT> </SEC-DOCUMENT>